Comparing allergy medicines added to nasal steroid for hay fever
Treatments studied
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial compares two add-on medicines (an antihistamine and an antileukotriene) when used with a standard nasal steroid spray to see which works better at controlling allergy symptoms. If you have moderate to severe hay fever and are not currently on allergy medication, this study may help you find a more effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults aged 18 to 60 years
- Diagnosed with allergic rhinitis (hay fever) with moderate to severe symptoms like a blocked or runny nose, sneezing, and itching
- Have not taken antihistamines, antileukotrienes, or steroid sprays for at least 2 weeks before starting
- No asthma, chronic sinusitis, nasal polyps, or other significant nasal problems
- Not pregnant or breastfeeding, and no allergy to the study medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a combination of probiotics (good bacteria) and vitamin D can help reduce hay fever symptoms. It may be a good option if your vitamin D is low and you haven't used probiotics recently.
This trial compares different ways to reduce rhinitis symptoms in people with moderate to severe nasal irritation. It may help find which treatment works best for you, depending on what type of rhinitis you have and your recent health and medication history.
This study compares two combination treatments for moderate to severe allergic rhinitis (hay fever). One group uses a corticosteroid nasal spray plus an antihistamine nasal spray, and the other uses the same spray plus an oral antihistamine pill. The goal is to see which combination better improves symptoms like sneezing, runny nose, and congestion.
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
This trial tests a new medicine for children with moderate to severe allergic rhinitis (a condition that causes a stuffy, runny, or itchy nose). It aims to see if the new medicine is safe and effective in reducing these symptoms compared to current treatments.
This trial is studying the bacteria in your nose and mouth during treatment with an allergy spray placed under your tongue. The goal is to understand how this treatment affects your allergy symptoms and your body's natural defenses.
Hear when a new Allergic Rhinitis (AR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.